Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)

Clinical trial NCT02582658 · COMPLETED

Trial details

NCT number: NCT02582658
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Hepatitis C

Start date: 2015-10-06
Primary completion: 2017-01-12
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.